Tag: Cancer: Lung
Adjuvant Therapy Ups Survival in Small-Cell Lung Cancer
Improved survival for chemotherapy with or without cranial irradiation versus surgery alone
Weight Appears to Impact Outcomes Post Lung CA Surgery
Both underweight and very obese had the highest odds for complications
Support for First-Line Erlotinib in NSCLC With EGFR Mutations
And erlotinib therapy beyond progression may delay salvage tx for some patients
Modifiable Factors Affect Racial Differences in Lung Cancer
No racial/ethnic differences in the risk of lung cancer death among women in fully adjusted models
Pembrolizumab Shows Promise in Metastatic NSCLC
In study, the immune-based therapy beat docetaxel with fewer side effects
Age at NSCLC Diagnosis Tied to Odds of Targetable Phenotype
Younger age at diagnosis linked to increased frequency of targetable phenotype
Toxic Skin Effects Common With EGFR-TKI Use in NSCLC
Afatinib therapy linked to earlier paronychia onset; more dermatological visits for skin toxic effects
FDA Approves Alecensa for ALK-Positive NSCLC
Drug is designed to block the effects of the ALK protein
FDA Approves Portrazza for Advanced Squamous NSCLC
Drug is designed to block activity of epidermal growth factor receptor protein
About Half of Pulmonologists Tend to Offer LDCT Screening
Overall, 52.4 percent have propensity for guideline-concordant low-dose CT screening
